Eptifibatide
Who holds supplier records for Eptifibatide? 12 organisations hold a current record for Eptifibatide: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (5), United States (1), Belgium (1), India (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Eptifibatide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/eptifibatide
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Eptifibatide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 23786 · latest filing Apr 2010
- AMBIOPHARM INCUnited StatesActive DMF 24864 · latest filing Apr 2011
- CHENGDU SHENGNUO BIOPHARM CO LTDChinaActive DMF 27651 · latest filing Dec 2013
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChinaActive DMF 31837 · latest filing Sept 2017
- HARBIN JIXIANGLONG BIOTECH CO LTDActive DMF 40034 · latest filing May 2024
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 26453 · latest filing Sept 2012
- PolypeptideBelgiumActive DMF 18565 · latest filing Aug 2005
- Sichuan Jisheng Biopharmaceutical Co.,LtdChinaActive DMF 41522 · latest filing Mar 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 26795 · latest filing Feb 2013
- TAPI NL BVNetherlandsActive DMF 21913 · latest filing Aug 2008
- WUXI KAILI PHARMACEUTICAL CO LTDActive DMF 26457 · latest filing Sept 2012
- Zhejiang Tasln Biopharma Co., Ltd.ChinaActive DMF 43557 · latest filing Jan 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (6)
Organisations whose Type II DMFs for Eptifibatide are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- HANGZHOU HAINA PHARMATECH CO LTDInactive DMF 31810 · filed Aug 2017
- POLYPEPTIDE LABORATORIES FRANCEInactive DMF 26757 · filed Dec 2012
- India · Inactive DMF 25092 · filed Jul 2011
- Italy · Inactive DMF 24933 · filed May 2011
- Netherlands · Inactive DMF 14267 · filed Jul 1999
- CORDEN PHARMA BRUSSELS SAInactive DMF 9915 · filed Oct 1992
Overview
Eptifibatide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1174).
Chemical identity
- IUPAC name
- 2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
- Canonical SMILES
- C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N
- InChIKey
- CZKPOZZJODAYPZ-LROMGURASA-N
- Synonyms
- Eptifibatida, Eptifibatide, Eptifibatide accord, Integrelin, Integrilin, CHEBI:291902, epifibatide, epifibratide, eptifibatidum, RefChem:56321, B01AC16, Intrifiban
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Platelet Aggregation Inhibitor
- Physiologic effect
- Decreased Platelet Aggregation
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Eptifibatide?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Eptifibatide: ALP PHARM BEIJING CO LTD, AMBIOPHARM INC (United States), CHENGDU SHENGNUO BIOPHARM CO LTD (China), HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (China), HARBIN JIXIANGLONG BIOTECH CO LTD, Hybio Pharmaceutical Co., Ltd. (China), Polypeptide (Belgium) and Sichuan Jisheng Biopharmaceutical Co.,Ltd (China), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Eptifibatide Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 23786), AMBIOPHARM INC (DMF 24864), CHENGDU SHENGNUO BIOPHARM CO LTD (DMF 27651), HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (DMF 31837), HARBIN JIXIANGLONG BIOTECH CO LTD (DMF 40034), Hybio Pharmaceutical Co., Ltd. (DMF 26453), Polypeptide (DMF 18565) and Sichuan Jisheng Biopharmaceutical Co.,Ltd (DMF 41522) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Eptifibatide records mean?
6 organisations have only inactive Type II DMFs for Eptifibatide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Eptifibatide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Eptifibatide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.